Search research articles
Contact Us
Filters
Showing results (181-190 of 196) with videos related to
Page
of 20
Sort By:
Journal of Internal Medicine
|
February 3, 2021
Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors
R Méndez, V Balanzá-Martínez, S C Luperdi, et al.
Acta Neuropsychiatrica
|
July 1, 2020
Interleukin-6 and total antioxidant capacity levels following <i>N</i>-acetylcysteine and a combination nutraceutical intervention in a randomised controlled trial for bipolar disorder
C C Bortolasci, C Voigt, A Turner, et al.
Molecular Psychiatry
|
September 9, 2015
Citalopram and sertraline exposure compromises embryonic bone development
D Fraher, J M Hodge, F M Collier, et al.
Neuroscience and Biobehavioral Reviews
|
October 12, 2010
Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors
M Berk, F Kapczinski, A C Andreazza, et al.
Molecular Psychiatry
|
March 13, 2013
Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis
S Smesny, B Milleit, U-C Hipler, et al.
Molecular Psychiatry
|
February 23, 2022
A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia
A J McGuinness, J A Davis, S L Dawson, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
December 15, 2015
A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up study
R Daglas, S M Cotton, K Allott, et al.
BMC Psychiatry
|
June 15, 2022
Counting on U training to enhance trusting relationships and mental health literacy among business advisors: protocol for a randomised controlled trial
L Saxon, S Bromfield, S H Leow-Taylor, et al.
Trials
|
November 30, 2019
ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis
S M Cotton, M Berk, A Watson, et al.
Current Pharmaceutical Design
|
January 14, 2012
Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder
A Bechdolf, A Ratheesh, S J Wood, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 196) with videos related to
Sort By:
Page
of 20
Journal of Internal Medicine
|
February 3, 2021
Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors
R Méndez, V Balanzá-Martínez, S C Luperdi, et al.
Acta Neuropsychiatrica
|
July 1, 2020
Interleukin-6 and total antioxidant capacity levels following <i>N</i>-acetylcysteine and a combination nutraceutical intervention in a randomised controlled trial for bipolar disorder
C C Bortolasci, C Voigt, A Turner, et al.
Molecular Psychiatry
|
September 9, 2015
Citalopram and sertraline exposure compromises embryonic bone development
D Fraher, J M Hodge, F M Collier, et al.
Neuroscience and Biobehavioral Reviews
|
October 12, 2010
Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors
M Berk, F Kapczinski, A C Andreazza, et al.
Molecular Psychiatry
|
March 13, 2013
Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis
S Smesny, B Milleit, U-C Hipler, et al.
Molecular Psychiatry
|
February 23, 2022
A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia
A J McGuinness, J A Davis, S L Dawson, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
December 15, 2015
A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up study
R Daglas, S M Cotton, K Allott, et al.
BMC Psychiatry
|
June 15, 2022
Counting on U training to enhance trusting relationships and mental health literacy among business advisors: protocol for a randomised controlled trial
L Saxon, S Bromfield, S H Leow-Taylor, et al.
Trials
|
November 30, 2019
ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis
S M Cotton, M Berk, A Watson, et al.
Current Pharmaceutical Design
|
January 14, 2012
Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder
A Bechdolf, A Ratheesh, S J Wood, et al.
Page
of 20